Haleon (HLN) Cash from Financing Activities (2021 - 2023)

Haleon (HLN) posted Cash from Financing Activities of -$841.5 million for Q4 2023, down 108.39% on a QoQ basis from $10.0 billion in Q4 2022, and down 108.39% year-over-year from $10.0 billion in Q4 2022.

Haleon (HLN) Cash from Financing Activities (2021 - 2023) Analysis & Trends

Haleon's Cash from Financing Activities history runs 3 years deep, the most recent figure standing at -$841.5 million for Q4 2023.

  • Quarterly Cash from Financing Activities fell 108.39% year-over-year to -$841.5 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $18.7 billion (changed N/A YoY) and the FY2025 annual result came in at -$4.1 billion, down 110.93% from the prior year.
  • Cash from Financing Activities was -$841.5 million for Q4 2023 at Haleon, down from $10.0 billion in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $10.5 billion in Q3 2022 and bottomed at -$965.2 million in Q4 2021.
  • A 3-year average of $4.7 billion and a median of $4.6 billion in 2022 frame the typical range for Cash from Financing Activities.
  • Annual changes were most pronounced in 2022 — Cash from Financing Activities surged 1138.55% — and 2023, when it sank 108.39%.
  • Haleon's Cash from Financing Activities stood at -$965.2 million in 2021, then jumped by 1138.55% to $10.0 billion in 2022, then sank by 108.39% to -$841.5 million in 2023.
  • Business Quant data shows HLN's Cash from Financing Activities at -$841.5 million in Q4 2023, $10.0 billion in Q4 2022, and $10.5 billion in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -840.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -494.13 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -1.48 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -203.80 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -86.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -65.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn -4.60 Mn

Historic Data

Download Data
DateValue
Dec 31, 2023 -841.50 Mn
Dec 31, 2023 -841.50 Mn
Dec 31, 2022 10.02 Bn
Dec 31, 2022 10.02 Bn
Sep 20, 2022 10.52 Bn
Sep 20, 2022 10.52 Bn
Dec 31, 2021 -965.18 Mn
Dec 31, 2021 -965.18 Mn